BMRN : Analysis & Opinions

  1. Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook

    March 25, 2014
    Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook
  2. Gilead Sciences Leads In Rising Short Interest Among Biotechs

    November 12, 2013
    Among leading biotech and emerging pharmaceutical companies, the number of shares sold short in Alexion Pharmaceuticals ...
  3. Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, ...

    September 14, 2013
    Declining short interest in Alexion Pharmaceuticals (NASDAQ: PCYC) bucked the trend among leading biotech and emerging pharmaceutical ...
  4. BioMarin Files Vimizim MA in Brazil - Analyst Blog

    July 5, 2013
    BioMarin is seeking Vimizim approval in Brazil.
  5. Celgene and More Big Movers in Healthcare on December 10, 2012

    December 10, 2012
    On a good day for the market, the Nasdaq is trading up 0.6%, the S&P 500 is up 0.2% and the Dow has increased 0.3%. The healthcare ...
  6. Celgene Among Healthcare's Biggest Movers on September 10, 2 ...

    September 10, 2012
    The Nasdaq has slipped 0.6%, the S&P 500 is unchanged and the Dow is trading up 0.1% after the morning's trading. The healthcare ...
  7. BioMarin Pharmaceutical Among Healthcare's Biggest Movers on ...

    August 20, 2012
    The market is having a bad day so far: the Nasdaq has slipped 0.2%; the S&P 500 is down 0.3%; and the Dow is trading down ...
  8. Betting On Healthcare's Growth Engine

    August 17, 2011
    In the wake of big pharma's patent cliff and slowing R&D spending, the biotech sector is looking good for investors.
  9. Is Another Wave Of Biotech M&A On The Way?

    July 2, 2010
    If biotech companies are buying each other, should investors get in on the action?
  10. Dendreon Hits The Big Time

    April 15, 2009
    Despite positive Phase 3 results, this medicine-maker's valuation is excessive and its new drug won't make it to market for ...
  11. Five Companies That Love (Earnings) Surprises

    June 20, 2008
    Stocks that can string together many quarters of positive earnings surprises are usually rewarded. Learn why the market loves ...
Investing News
  1. 3 Dumb Ways to Borrow Money

    Money — everyone needs it, but not everyone has it. Many people who find themselves in a ...
  2. Infographic - The Lifecycle of a Bond

    Basic information on how Bonds work.
  3. What $200,000 Will Buy In The Atlanta Real Estate Market

    Atlanta housing prices are up from last year, but they're still lower than the national median. ...
  4. Bubble Bursting? Only For Biotech & Internet Stocks

    The recent sluggish performance of U.S. stocks is leading some market watchers to question ...
  5. What $300,000 Will Buy In The Riverside/San Bernardino Real Estate Market

    The median list price for the San Bernardino/Riverside, Calif. market is $292,800, up 24.6% ...
  6. What Is Worse Than Being At Risk?

    You may have heard the old adage: “What is worse than being lost? Not knowing you are lost.” ...
Trading Center